Literature DB >> 4099592

The effect of cortisone treatment on autologous immune complex glomerulonephritis in rats.

A Z Barabas, A H Nagi, R Lannigan, R A Womersley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4099592      PMCID： PMC2072353     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  4 in total

1.  Experimental auto-immune nephrosis in rats: III.

Authors:  W HEYMANN; J L HUNTER; D B HACKEL
Journal:  J Immunol       Date:  1962-02       Impact factor: 5.422

2.  Preparation of specific anti-chicken immunoglobulin sera.

Authors:  A Z Barabas; H Barabas
Journal:  Clin Exp Immunol       Date:  1969-05       Impact factor: 4.330

3.  Preliminary observations on the effect of heterologous anti-lymphocytic globulin on autologous immune complex nephritis in rats.

Authors:  A Z Barabas; K James; R Lannigan
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

4.  Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism.

Authors:  R J Glassock; T S Edgington; J I Watson; F J Dixon
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307
  4 in total
  10 in total

1.  Induction of experimental autologous immune-complex glomerulonephritis by eluted gamma-globulin.

Authors:  A Z Barabas; A H Nagi; R Lannigan
Journal:  Int Urol Nephrol       Date:  1971       Impact factor: 2.370

2.  Induction of an autologous immune-complex glomerulonephritis in the rat by intravenous injection of heterologous anti-rat kidney tubular antibody. I. Production of chronic progressive immune-complex glomerulonephritis.

Authors:  A Z Barabas; R Lannigan
Journal:  Br J Exp Pathol       Date:  1974-02

3.  Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-12       Impact factor: 1.925

4.  FK506, a novel immunosuppressive agent, induces antigen-specific immunotolerance in active Heymann's nephritis and in the autologous phase of Masugi nephritis.

Authors:  Y Okubo; Y Tsukada; A Maezawa; K Ono; S Yano; T Naruse
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

5.  Gold nephropathy in rabbits using an indigenous preparation. A morphological study.

Authors:  A H Nagi; A H Khan
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

6.  Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Jord M Cowan; Chang Soon Yoon; David M Waisman; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

7.  Production of Heymann nephritis by a chemically modified renal antigen.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

8.  Production of a new model of slowly progressive Heymann nephritis.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2003-12       Impact factor: 1.925

9.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03

10.  Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.

Authors:  M Nakazawa; S N Emancipator; M E Lamm
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.